SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1890Medarex Announces Allowance of Investigational New Drug Applications for Wholly Icebrg-12/4/2007
1889Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell CancIcebrg-12/1/2007
1888I know a Chuck Baum from SyStemix...... nice guy, if it's the same Charlesscaram(o)uche-11/29/2007
1887Pfizer Oncology Head Charles Baum: An Interview With "The Pink Sheet" Icebrg-11/28/2007
1886Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal StuIcebrg-11/28/2007
1885PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion andIcebrg-11/25/2007
1884How HIV "Exhausts" Killer T Cells American and South African scientisIcebrg-11/25/2007
1883Avant has pretty much sold (monatized) all its interest in Rotarix. The companyTettra-11/23/2007
1882Glaxo rotavirus vaccine highly effective: study Thu Nov 22, 2007 7:21pm EST LONIcebrg-11/23/2007
1881AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine to Enter PhaseIcebrg-11/19/2007
1880Centocor seeks to extend profits with new products Philadelphia Business JournalIcebrg-11/10/2007
1879Genmab to Present Zanolimumab and Ofatumumab Data at ASH COPENHAGEN, November 9Icebrg-11/10/2007
1878[1646] Clinical Trial of Therapeutic Blockade of CTLA4 with Ipilimumab in PatienIcebrg-11/9/2007
1877>>Before year-end. << That probably explains why the January 12.5, 1tnsaf-11/9/2007
1876Don Drakeman joins 4- Antibody Board [They forgot to mention that he is also anIcebrg-11/9/2007
1875Before year-end. ErikIcebrg-11/8/2007
1874Erik, Any idea when to expect the top line Ipilimumab Phase 3 results? Shouldngfp927-11/8/2007
1873Medarex Announces Presentations on UltiMAb(R) Antibodies at 71st Annual Meeting Icebrg-11/8/2007
1872&J, Schering-Plough arthritis drug meets goals Wed Nov 7, 2007 5:36pm EST ByIcebrg-11/7/2007
1871Medarex Announces Election of Marc Rubin as New Board Member Wednesday November Icebrg-11/7/2007
1870Prognostic Factors Related to Clinical Response in Patients with Metastatic MelaIcebrg-11/6/2007
1869Targeting Melanoma Robert Langreth 11.12.07 URL: members.forbes.com A new arseIcebrg-11/2/2007
1868IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well ToleraIcebrg-11/2/2007
1867IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease CIcebrg-11/2/2007
1866IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) CompassionateIcebrg-11/2/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News